Pancreatic cancer remains one of the deadliest cancers, but researchers at National Taiwan University Hospital have developed an AI-assisted model to detect small tumors with 80% sensitivity, offering hope for earlier diagnosis. Taiwan’s AI innovations in healthcare, supported by its universal healthcare system and robust medical data, are transforming cancer detection and treatment.
As Taiwan navigates the challenges of a super-aged population, GSK leads with innovative solutions, focusing on prevention and treatment. By uniting science, technology, and talent, the company aims to improve health outcomes for Taiwan and beyond.
Fran Milnes, Country President of Novartis Taiwan, reflects on her journey in the pharmaceutical industry, emphasizing her focus on innovation, patient-centered care, and leadership adaptability. From championing preventive health campaigns to embracing cultural nuances as a leader in Taiwan, she highlights the importance of equity, mentorship, and bold aspirations for women in leadership.
Taiwan is intensifying efforts to combat cardiovascular disease, the nation’s second leading cause of death, through initiatives like the NHIA’s 888 Plan and telehealth innovations from iXensor. A focus on preventive care, early intervention, and expanded access to advanced treatments aims to improve outcomes and reduce healthcare burdens.
Drug repurposing revitalizes existing drugs for new uses, offering faster, affordable medical solutions. Taiwan is emerging as a leader in this innovative approach, with treatments like aspirin for heart health and remdesivir for Covid-19.
Veneers are transforming cosmetic dentistry, offering precise, efficient treatments that enhance both appearance and function. Achieving the perfect smile requires a blend of technology, artistry, and careful consideration of natural teeth.
With 175 years of history comes a crystal-clear vision of the future: a bold, innovative, and robust generation of leaders raised by Pfizer Taiwan, striving to help one billion lives globally in 2027. This wave of talent is guided by Pfizer’s four core values – Courage, Excellence, Equity, and Joy – delivering world-class growth and…
As cardiometabolic diseases, such as Type 2 diabetes and obesity, continue to rise globally, the healthcare industry faces unprecedented challenges. According to the World Health Organization (WHO), more than one billion people are affected by obesity, an alarming figure that spurred the coining of the term “globesity.” Obesity is not only a significant health issue…
In September, Taiwan’s National Health Insurance Administration expanded coverage to 46 da Vinci robotic-assisted surgeries, benefiting 8,400 patients annually. Patients now only pay material copayments, adding NT$285 million (US$8.75 million) to the NHI budget. This change boosts healthcare efficiency and improves patient outcomes, with fewer complications and faster recoveries, making robotic-assisted surgery a cost-effective long-term solution despite initial costs.
Becton, Dickinson and Co. (BD) has evolved from a syringe manufacturer into a leading MedTech company, driving digital transformation in healthcare with solutions like automated pharmacy systems that improve efficiency and patient outcomes. In Taiwan, BD’s innovations align with the government’s “Healthy Taiwan” initiative, as the country aims to establish itself as a MedTech hub. Despite Taiwan’s strengths in electronics and healthcare, challenges such as improving software and aligning regulatory standards with global norms remain. As AI becomes integral to healthcare, addressing these issues will be crucial for Taiwan’s MedTech competitiveness.
